Phosphorus Education and Adherence in Hemodialysis Patients
Launched by JEN-AI HOSPITAL INSTITUTIONAL REVIEW BOARD · Jul 20, 2025
Trial Information
Current as of August 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who have been on dialysis for more than one year, have intact self-awareness, and are currently taking phosphate-binding medications.
- Exclusion Criteria:
- • Patients who have been on dialysis for less than one year, lack self-awareness, or are not taking phosphate-lowering medications.
About Jen Ai Hospital Institutional Review Board
The Jen-Ai Hospital Institutional Review Board (IRB) is a dedicated ethical oversight body committed to ensuring the safety, rights, and welfare of human subjects participating in clinical research. Operating within the framework of established regulatory guidelines, the IRB reviews research proposals to assess their scientific validity and ethical considerations. By fostering a collaborative environment between researchers and participants, Jen-Ai Hospital IRB aims to uphold the highest standards of integrity and compliance in clinical trials, thereby advancing medical knowledge while prioritizing participant protection.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported